Leukemia - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Comparing Treatments for Chronic Myelogenous Leukemia
(Posted: 02/13/2007) - In this trial, doctors will compare the effectiveness of imatinib (Gleevec) at the standard dose versus an increased dose and against a new drug called dasatinib (Sprycel) as initial therapy for chronic myelogenous leukemia.
- Studying Chronic Graft-versus-Host Disease
(Posted: 07/18/2006) - In this study, researchers are interested in determining the natural history of chronic graft-versus-host disease and assessing biological factors that may predict outcomes associated with it.
- Studying Dyskeratosis Congenita
(Posted: 07/11/2006) - Persons with a rare disorder called dyskeratosis congenita (DC) tend to have a high risk of developing bone marrow failure, leukemia, or certain carcinomas. NCI is undertaking an intensive assessment of families with DC to learn more about how genes associated with it lead to cancer development and to identify new susceptibility genes for DC.
- Preventing Graft-versus-Host Disease during Hematologic Cancer Treatment
(Posted: 05/31/2005) - Researchers are investigating whether an immunosuppressive drug, sirolimus, can work with cyclosporine to prevent graft-versus-host disease (GVHD) more effectively than cyclosporine alone following allogeneic hematopoietic stem cell transplantation.
- Study of Individuals and Families at High Risk for Blood Cancers
(Posted: 07/27/2004) - Researchers want to study individuals and families who may have a genetic predisposition to developing hematologic cancers. Studying this population may help identify other persons at risk, precursor conditions, clues to etiology, and the genes involved in these malignancies.